Hyunjung Lee1, Young In Kim1,2, Farida S Nirmala1,3, Ji-Sun Kim4, Hyo-Deok Seo1, Tae Youl Ha1,3, Young-Jin Jang1, Chang Hwa Jung1,3, Jiyun Ahn1,3. 1. Research Group of Natural Material and Metabolism, Korea Food Research Institute, Wanju, South Korea. 2. Department of Food Science and Technology, Jeonbuk National University, Jeonju-Si, South Korea. 3. Department of Food Biotechnology, University of Science and Technology, Daejeon, South Korea. 4. Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, South Korea.
Abstract
Post-menopausal conditions exacerbate the biological aging process and this is often accompanied by visceral adiposity with sarcopenia. Mitochondrial impairment is a hallmark of frailty and sarcopenia in the elderly. However, the exact mechanism underlying the development of obesogenic sarcopenia and the involvement of mitochondria remains unclear. This study confirmed that there is a decline in muscle mass and function as well as mitochondrial dysfunction in the quadriceps of ovariectomized (OVX) mice. To investigate the role of microRNA (miRNA) in this process, we performed miRNA and mRNA arrays and found that miR-141-3p directly targets and downregulates FK506 binding protein 5 (Fkbp5) and Fibin. Overexpression of miR-141-3p decreased mitochondrial function and inhibited myogenic differentiation in C2C12 cells. These effects were mediated by Fkbp5 and Fibin inhibition. Conversely, knockdown of miR-141-3p increased mitochondrial respiration and enhanced myogenesis. Treatment with β-estradiol effectively reversed the palmitic acid-induced upregulation of miR-141-3p and subsequent downregulation of Fkbp5 and Fibin. In conclusion, miR-141-3p is upregulated in OVX mice, and this is associated with mitochondrial dysfunction through inhibition of Fkbp5 and Fibin. These findings suggest that inhibiting miR-141-3p could be a therapeutic target for alleviating obesogenic sarcopenia.
Post-menopausal conditions exacerbate the biologipan class="Gene">cal aging process and this is often accompanied by visceral adiposity with sarcopenia. Mitochondrial impairment is a hallmark of frailty and sarcopenia in the elderly. However, the exact mechanism underlying the development of obesogenic sarcopenia and the involvement of mitochondria remains unclear. This study confirmed that there is a decline in muscle mass and function as well as mitochondrial dysfunction in the quadriceps of ovariectomized (OVX) mice. To investigate the role of microRNA (miRNA) in this process, we performed miRNA and mRNA arrays and found that miR-141-3p directly targets and downregulates FK506 binding protein 5 (Fkbp5) and Fibin. Overexpression of miR-141-3p decreased mitochondrial function and inhibited myogenic differentiation in C2C12 cells. These effects were mediated by Fkbp5 and Fibin inhibition. Conversely, knockdown of miR-141-3p increased mitochondrial respiration and enhanced myogenesis. Treatment with β-estradiol effectively reversed the palmitic acid-induced upregulation of miR-141-3p and subsequent downregulation of Fkbp5 and Fibin. In conclusion, miR-141-3p is upregulated in OVX mice, and this is associated with mitochondrial dysfunction through inhibition of Fkbp5 and Fibin. These findings suggest that inhibiting miR-141-3p could be a therapeutic target for alleviating obesogenic sarcopenia.
Authors: P M Coen; K C Hames; E M Leachman; J P DeLany; V B Ritov; E V Menshikova; J J Dubé; M Stefanovic-Racic; F G S Toledo; B H Goodpaster Journal: Obesity (Silver Spring) Date: 2013-05-31 Impact factor: 5.002
Authors: John A Batsis; Todd A Mackenzie; Rebecca T Emeny; Francisco Lopez-Jimenez; Stephen J Bartels Journal: J Gerontol A Biol Sci Med Sci Date: 2017-10-01 Impact factor: 6.053
Authors: Smeeta Shrestha; Yang Sun; Thomas Lufkin; Petra Kraus; Yuzuan Or; Yenni A Garcia; Naihsuan Guy; Paola Ramos; Marc B Cox; Fiona Tay; Valerie C L Lin Journal: Int J Biol Sci Date: 2015-02-27 Impact factor: 6.580
Authors: Pasquale Mone; Antonio de Donato; Fahimeh Varzideh; Urna Kansakar; Stanislovas S Jankauskas; Antonella Pansini; Gaetano Santulli Journal: Front Aging Date: 2022-07-18